Profile cover photo
Profile photo
The Oncologist
142 followers
142 followers
About
Posts

Post has attachment
Add a comment...

Post has attachment
Discussions with Don S. Dizon
On Patient Care and Equipoise - overcoming our own biases with regard to who should participate in a clinical trial is important to ensuring their success. -
Photo
Add a comment...

Post has attachment
New CME available -- Applying New Data on Leukemia and Lymphoma to Oncology Practice: Case-Based Insights from ASH 2017

http://ow.ly/x6mX30jyKTd
Photo
Add a comment...

Post has attachment
Melanoma: What do all the mutations mean? - Davis - - Cancer
Add a comment...

Post has attachment
The Concept of Biosimilars: From Characterization to Evolution—A Narrative Review
This article clarifies the concept of biosimilars in all therapeutic classes, including definition, history, market entry, challenges, and future evolution.
http://ow.ly/OU3k30jlnRU
Add a comment...

Post has attachment
Add a comment...

Post has attachment
A comprehensive overview of current treatment options for patients with advanced clear‐cell renal cell carcinoma (RCC) whose disease has progressed after their first therapy.
Add a comment...

Post has attachment
In support of this mission, the Editors of The Oncologist present this collection of articles on topics ranging from barriers to screening to promising treatment advances, all from researchers around the world, committed to doing their part in the global fight against cancer.
World Cancer Day 2018 - The Oncologist
World Cancer Day 2018 - The Oncologist
theoncologist.alphamedpress.org
Add a comment...

Post has attachment

Post has attachment
This article reports a series of 114,200 consecutive clinical cases with comprehensive genomic profiles available to identify ALK fusions that could facilitate the use of precision medicine in both non‐small cell lung cancer (NSCLC) and non‐NSCLC malignancies.
Add a comment...
Wait while more posts are being loaded